Showing 1 - 8 results of 8 for search 'Matthew D Marsden', query time: 0.03s Refine Results
  1. 1
    Benefits and limitations of humanized mice in HIV persistence studies

    Benefits and limitations of humanized mice in HIV persistence studies by Matthew D. Marsden

    Published 2020-04-01
    Get full text
    Article
  2. 2
    Contribution of Sex Differences to HIV Immunology, Pathogenesis, and Cure Approaches

    Contribution of Sex Differences to HIV Immunology, Pathogenesis, and Cure Approaches by Jose A. Moran, Shireen R. Turner, Matthew D. Marsden, Matthew D. Marsden

    Published 2022-05-01
    Get full text
    Article
  3. 3
    RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT Mice

    RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT Mice by Saki Shimizu, Gene-Errol Ringpis, Matthew D Marsden, Ruth V Cortado, Holly M Wilhalme, David Elashoff, Jerome A Zack, Irvin S Y Chen, Dong Sung An

    Published 2015-01-01
    Get full text
    Article
  4. 4
    Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy

    Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy by Clayton Hardman, Stephen Ho, Akira Shimizu, Quang Luu-Nguyen, Jack L. Sloane, Mohamed S. A. Soliman, Matthew D. Marsden, Jerome A. Zack, Paul A. Wender

    Published 2020-04-01
    Get full text
    Article
  5. 5
    Disruption of Type I Interferon Induction by HIV Infection of T Cells.

    Disruption of Type I Interferon Induction by HIV Infection of T Cells. by David Jesse Sanchez, Daniel Miranda, Matthew D Marsden, Thomas Michael A Dizon, Johnny R Bontemps, Sergio J Davila, Lara E Del Mundo, Thai Ha, Ashkon Senaati, Jerome A Zack, Genhong Cheng

    Published 2015-01-01
    Get full text
    Article
  6. 6
    In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication.

    In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication. by Matthew D Marsden, Brian A Loy, Xiaomeng Wu, Christina M Ramirez, Adam J Schrier, Danielle Murray, Akira Shimizu, Steven M Ryckbosch, Katherine E Near, Tae-Wook Chun, Paul A Wender, Jerome A Zack

    Published 2017-09-01
    Get full text
    Article
  7. 7
    Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo

    Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo by Lars Pache, Matthew D. Marsden, Peter Teriete, Alex J. Portillo, Dominik Heimann, Jocelyn T. Kim, Mohamed S.A. Soliman, Melanie Dimapasoc, Camille Carmona, Maria Celeridad, Adam M. Spivak, Vicente Planelles, Nicholas D.P. Cosford, Jerome A. Zack, Sumit K. Chanda

    Published 2020-06-01
    Get full text
    Article
  8. 8
    Latency reversal plus natural killer cells diminish HIV reservoir in vivo

    Latency reversal plus natural killer cells diminish HIV reservoir in vivo by Jocelyn T. Kim, Tian-Hao Zhang, Camille Carmona, Bryanna Lee, Christopher S. Seet, Matthew Kostelny, Nisarg Shah, Hongying Chen, Kylie Farrell, Mohamed S. A. Soliman, Melanie Dimapasoc, Michelle Sinani, Kenia Yazmin Reyna Blanco, David Bojorquez, Hong Jiang, Yuan Shi, Yushen Du, Natalia L. Komarova, Dominik Wodarz, Paul A. Wender, Matthew D. Marsden, Ren Sun, Jerome A. Zack

    Published 2022-01-01
    Get full text
    Article

Search Tools: